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Heart failure is the major cause of mortality, morbidity and hospitalisation 
in patients age > 60 years(1). Despite major advances in medical therapy, 
morbidity and mortality remain high. Cardiac resynchronisation therapy 
(CRT) has been found to provide signifi cant clinical benefi t in patients 
with impaired left ventricular (LV) function, prolonged QRS duration 
and New York Heart Association (NYHA) functional class III/IV 
heart failure despite optimal drug therapy(2,3).  Studies have shown that 
CRT improves NYHA functional class, exercise capacity, quality of life 
and LV systolic function. This is accompanied by a reduction in 
hospitalisation and a signifi cant improvement in survival, as confi rmed 
in the CARE-HF study(4). 
Cardiac Resynchronisation Therapy: 
The Role of Echocardiography in 
Patient Selection and Follow-up
Despite these astonishing results, clinicians have only begun to 
understand the mechanisms responsible for improvement. Clinicians 
are struggling to identify those most and least likely to derive benefi t 
from CRT and continue to perfect the technique. Currently, patients 
who remain signifi cantly symptomatic despite optimal medical therapy 
are selected mainly on electrocardiogram (ECG) criteria (QRS interval 
>120ms )(5). However, using these selection criteria, about 20% to 30% 
of patients do not respond to CRT. Different factors may infl uence the 
ability of CRT to improve clinical outcome, such as patient selection, 
device programming, lead position and various arrhythmias that result 
in intermittent CRT delivery.
A major limitation has been the utilisation of the QRS duration as the 
only marker for dyssynchrony. However, substantial mechanical 
dyssynchrony, a major predictor of response to CRT, is not necessarily 
related to electrical dyssynchrony(6,7). QRS width often does not change 
following CRT and evidence is confl icting as to whether baseline QRS 
width predicts who will respond to CRT(8). In addition, substantial 
dyssynchrony may be present in heart failure patients with a normal 
QRS(9,10). The presence of LBBB may only identify about half of all 
patients with mechanical dyssynchrony(8,11). 
Mechanical dyssynchrony is complex and should be evaluated at 
3 levels. These include:
1. Atrioventricular (AV) dyssynchrony, which results in delayed 
contraction between the atria and the ventricles. This may produce 
systolic mitral and tricuspid regurgitation. When the AV delay is 
excessive, a gap occurs between the end of atrial fi lling (A wave) 
and the beginning of left ventricular contraction. During this delay, 
the mitral valve closes passively (soft fi rst heart sound), as the left 
atrial pressure falls below LV pressure during late diastole, so that 
diastolic mitral regurgitation may occur.  The shortened ventricular 
fi lling time limits net diastolic stroke volume(12). Atrial systole occurs 
during early passive fi lling and this further reduces LV fi lling(13). When 
the AV delay is too short, the left atrial systolic peak pressure occurs 
after the onset of LV systole. As a result, the left atrial contraction is 
not able to open the mitral valve because LV pressure greatly 
exceeds the left atrial peak pressure. The mean left atrial pressure is 
increased, with possible symptoms of pulmonary congestion. 
2. Interventricular dyssynchrony, which is associated with an earlier 
onset of right ventricular (RV) contraction and ejection, during the 
LV end-diastolic period. The higher RV pressure displaces the septum 
into the LV, resulting in decreased mechanical performance(14).










Resynchronisation of segmental left ventricular 
mechanics as well as re-coordination of both atrioventricular and 
interventricular mechanics are potential mechanisms for the 
clinical improvement observed in patients undergoing cardiac 
resynchronisation therapy (CRT) for heart failure. Resynchro-
nisation therapy is approved in patients with refractory heart failure 
symptoms despite optimal medical therapy. The presence of a 
prolonged QRS duration has been the main criterion used to identify 
ventricular dyssynchrony. However, based on the current selection 
criteria, about 20% to 30% of patients do not improve after 
biventricular pacing. Using echocardiography, dyssynchrony may be 
absent in some heart failure patients with a wide QRS, or present in 
those with a normal QRS interval.
Echocardiography, and especially the more sophisticated techniques 
based on Tissue Doppler Imaging, may improve patient selection by 
identifying inter- and intra-ventricular dyssynchrony. Echocardiography 
can also be used to optimise lead placement. Following pacemaker 
implantation, various echocardiographic techniques can be used 
to ensure optimal cardiac resynchronisation and to monitor 
improvements in left ventricular function and hemodynamics. In 
this review, the different echocardiographic approaches to 
predict patient response to CRT are discussed. In addition, the use 
of echocardiography to guide lead positioning and to optimise 
pacemaker settings following pacemaker implantation is discussed.
ABSTRACT
CRT - ROLE OF 
ECHOCARDIOGRAPHY
39
3. Intraventricular dyssynchrony, which is associated with a reduction in 
ventricular performance and global LV ejection fraction(15). There is 
wasted work with either early or delayed regional myocardial 
contraction. The latter may even be delayed to early diastole(16). The 
early contraction occurs when pressure is low and does not lead to 
ejection. The late contraction occurs at higher stresses and results in 
paradoxical stretch of any earlier contracting segments. The net 
result is a decline in systolic performance(17). Delayed early relaxation 
shortens LV fi lling time, whilst delayed papillary muscle contraction 
contributes to mitral regurgitation. 
Considering the limitations of conventional ECG, various echocardio-
graphic techniques, some quite novel, have been developed to 
determine the extent of mechanical dyssynchrony. These include 
conventional 2-dimensional (2D) and Doppler echocardiography and 
newer Tissue Doppler methods. There is currently no consensus on the 
defi nition of echocardiographically measured dyssynchrony.
CONVENTIONAL ECHOCARDIOGRAPHY                   
Pitzalis and colleagues utilized standard M-mode echocardiography to 
measure the extent of septal-to-lateral wall motion delay as derived 
from the parasternal short-axis view(8). A delay >130ms has been 
proposed as a marker of intraventricular dyssynchrony and has been 
shown to be a powerful predictor of reverse remodeling. This index 
cannot be derived in patients with an akinetic septum or posterior wall 
and it is not always possible to get perpendicular M-mode sections 
through the LV. 
Interventricular mechanical delay (IVMD) can also be determined using 
pulsed Doppler. The time difference between the onset of the 
pulmonary fl ow and the aortic fl ow > 40ms is considered indicative 
of interventricular dyssynchrony(18,19). In the CARE-HF study, a 
prolonged aortic pre-ejection delay (>140ms) was an additional 
criterion refl ecting interventricular delay in those with a QRS interval 
between 120ms -150ms(4).
TISSUE DOPPLER IMAGING (TDI), TISSUE-                 
TRACKING, STRAIN AND STRAIN RATE
With the limited role of conventional echocardiography in the 
assessment of cardiac dyssynchrony, several newer echocardiographic 
applications have emerged with potential application in CRT. These 
include the following: 
Tissue Velocity Imaging
Tissue Velocity Imaging (TVI) uses myocardial Doppler frequency shifts 
to quantify regional myocardial function by measuring segmental peak 
systolic and diastolic tissue velocities. TVI can be displayed as pulsed 
Doppler (Figure 1), colour Doppler (Figure 2) and colour M-mode. The 
2D colour TVI image can be converted to TVI waveforms to allow 
further off-line quantitative analysis (Figure 3). 
Vol. 4, No. 2, 2007
FIGURE 1: Pulse Wave Tissue Velocity Imaging
Pulsed Doppler interrogation measures the instantaneous peak velocities from the 
myocardium which passes through the sample volume during the cardiac cycle. The 
sharp narrow positive spike represents myocardial velocity during the isovolumic 
contraction period. This is followed by a broad dominant positive waveform representing 
myocardial velocity during the ejection phase. There are two dominant negative 
waveforms (below the line) which represent myocardial velocity during rapid atrial ﬁ lling 
(E-wave) and atrial contraction (A-wave), respectively.
FIGURE 2: Colour Tissue Velocity Imaging






Interventricular dyssynchrony has been defi ned by the difference in 
time-to-peak myocardial velocities between one RV segment and the 
mean of 6 LV myocardial segments in the apical 4-chamber, 2-chamber 
and long-axis views(20).
Intraventricular dyssynchrony is present when there is a delay of 
>60ms in the time to onset of peak systolic velocities from the QRS 
complex using a 2-sample model (basal septum and basal lateral 
wall)(21,22). In a more complex and time-consuming 12-segment model, 
derived from the 6 basal and 6 mid-ventricular segments,(10) Yu and 
colleagues defi ned intraventricular dyssynchrony as present when:
a)  there was a >100ms difference between the peak systolic velocities 
of any 2 of 12 LV segments or
b)  the SD (standard deviation) of all time intervals measuring time to 
peak systolic velocity in 12 LV segments was >33ms.
Tissue Tracking
Although TVI is used to identify areas of dyssynchrony, it is limited by 
the fact that it does not allow simultaneous comparison of regional 
timing in different segments within one cardiac cycle. Tissue Doppler 
measures the velocity at a single point and cannot discriminate between 
passive myocardial motion as a result of tethering and active myocardial 
contraction(23). TVI technology includes tissue tracking and strain rate 
imaging. Tissue tracking is performed in the apical view and allows the 
measurement and visualisation of longitudinal motion in each cardiac 
segment during the different phases of the cardiac cycle. This is done by 
integrating tissue velocities to yield tissue displacement, which measures 
the total distance that particular point travels. Tissue Tracking is displayed 
as a colour band representing motion during systole. Each point in the 
myocardium is colour coded, with displacement occurring from end-
diastole to end-systole. The width of each colour bar is a measure of 
regional strain over the time period interrogated (Figure 4).
Tissue synchronisation imaging (TSI) is a parametric imaging tool 
derived from 2-dimensional (2D) TVI images. It automatically calculates 
and colour-codes the time-to-peak tissue velocity in every portion in 
the image, with reference to the QRS signal. The TSI algorithm detects 
positive velocity peaks within a specifi ed time interval. The colour 
coding ranges from green (earliest), yellow, orange, to red (latest) within 
this interval.  With TSI, the colour represents the amount of tissue 
motion delay rather than the absolute value of the tissue velocity. The 
variation in colour provides both a quantitative and qualitative 
FIGURE 3: The regional velocity sampled from the basal septum in this normal subject 
is displayed in the diagram on the right. Conventionally, systolic motion of segments 
towards the apex (and hence the transducer) is ascribed a positive value while shortening 
of a segment is ascribed a negative value. Aortic valve opening and closure are displayed 
to enable accurate timing of mechanical events within the cardiac cycle.
FIGURE 4: Tissue tracking displays systolic longitudinal displacement by integrating tissue velocity over time. Tissue Tracking is displayed as a colour band representing motion during 
systole. The system colour-codes each point in the myocardium with the displacement occurring from the end-diastole to end-systole. A normal left ventricle displays the lowest motion at 
the apex (shown as white in the diagram), while the mitral annulus will display the greatest motion. Systolic mitral annular displacement, determined by tissue tracking, correlates closely 




















representation of wall motion delay, allowing immediate identifi cation 
of regional delay in systole by comparing the colour mapping of 
orthogonal walls (Figure 5 and 6)(24,25). 
Various TSI parameters have been used to predict an improvement in 
clinical outcome. Murphy, et al. used TSI to identify the area of latest 
peak systolic velocity before CRT. Pacing at this site resulted in the 
greatest clinical and hemodynamic improvement(26). Whilst Yu, et al, 
confi rmed that the time-to-peak systolic velocity (Ts) measured in the 
ejection phase in 12 LV segments, derived in the apical view, was the 
best modality to predict reverse LV remodeling after CRT. When the 
lateral wall is delayed, the patient has a high likelihood of response to 
CRT(27).  In the absence of lateral wall delay, patients unlikely to respond 
to CRT were identifi ed when the systolic synchronicity index, defi ned 
as the standard deviation of the peak tissue velocity in 12 LV segments 
in the ejection phase, was < 34.4ms.
Although this study did not fi nd that post-systolic shortening (PSS), 
defi ned as contraction after aortic valve closure, was useful for the 
identifi cation of responders, others have shown that, in non-ischemic 
heart failure, the presence of PSS in more than 20% of the basal segments 
on all three apical views was predictive of clinical improvement(28).
Strain and Strain Rate
The temporal analysis of myocardial motion by velocity imaging allows 
no defi nite conclusions about the timing of regional contraction. As 
already discussed, velocity imaging cannot differentiate passive 
myocardial motion related to tethering artefacts or cardiac translation 
from active myocardial contraction. To overcome the limitations of 
velocity imaging, strain and strain rate imaging have been developed to 
identify the regional deformation properties of the myocardium. The 
information is derived from tissue Doppler velocity data and measures 
the timing and extent of myocardial deformation. Strain measures the 
change in shape of myocardial segments and strain rate imaging 
measures how fast the change has occurred (Figures 7, 8). Strain is 
defi ned as the change in length normalized to the initial length of the 
myocardium and is therefore expressed as a percentage. Strain 
measures the activity of 2 points within the myocardium. Because the 
length at peak systole is shorter than the original length, strain (and 
strain rate) has a negative polarity when measured in the longitudinal 
axis(29). The opposite occurs in the short-axis plane (radial) when the 
myocardium thickens during systole so that strain and strain rate have 
a positive polarity. 
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FIGURE 5: Tissue Synchronized Imaging is a parametric imaging tool based on Tissue 
Velocity Imaging that provides clinicians with additional image enhancement for 
assessing delayed cardiac motion. The TSI parametric image analyzes the tissue velocity 
signals within a speciﬁ ed portion of the cardiac cycle. Since these peaks will occur in 
relation to overall motion, delayed wall motion will produce a delayed peak velocity. The 
amount of delay within a deﬁ ned area of the cardiac cycle, indicated by the markers on 
the ECG, is used to assign or map a colour to that location in the image. The colour 
represents the amount of tissue motion delay rather than the absolute value of the tissue 
velocity. The variation in colour provides both a qualitative and quantitative representation 
of wall motion delay, allowing easy and rapid identiﬁ cation and evaluation of 
asynchronous wall motion. The ﬁ gure depicts a normal study with all regions shown in 
green, reaching peak velocity at the same time early in systole.
FIGURE 6: Utilizing Tissue Synchronized Imaging, it is easy to appreciate the 
dyssynchronous regions in the left ventricle. The regions which reach peak velocities at 
different times have different colours, with the red areas being most delayed.
FIGURE 7: Strain Imaging provides regional detection of myocardial contraction. 
Strain measures the percent of regional deformation of the myocardium (percentage 
change in length). Systolic motion of the segments towards the apex (towards the 
transducer) is ascribed a positive value and shortening of the segment a negative strain 
value. The opposite will apply to regional lengthening. The diagram depicts a normal 
study with negative strain during systole in the basal septum. There is no lengthening of 
the myocardial segment during this time interval.
Strain and strain rate imaging measure myocardial deformation in 
systole and are able to identify reliably the presence of delayed 
contractions and thus the presence of a recruitable contractile reserve 
that can be utilized by CRT, by transferring it from the pre or post-
ejection period to the systolic ejection phase. Ischemic myocardial 
segments can also display PSS. These delayed segments would not be 
expected to respond to CRT.
REAL-TIME THREE-DIMENSIONAL                                 
ECHOCARDIOGRAPHY
This novel imaging modality allows functional assessment of all 16 
individual segments of the LV. A cast of the LV is obtained and regional 
volume curves are obtained. A dyssynchrony index is obtained by 
calculating the time taken to each minimal volume for each segment as 
a percentage of the cardiac cycle. This is expressed as a percentage of 
the duration of the cardiac cycle to allow comparison between patients 
with different heart rates. Using this technique, it has been shown that 
mechanical dyssynchrony is increasingly prevalent with worsening LV 
function, independently of  QRS duration(9).
ECHOCARDIOGRAPHY AND LV LEAD PLACEMENT 
One of the challenges for the echocardiographer is to identify the 
optimal LV segment for placement of the LV lead. Pacing in the “wrong” 
area may account for a failed response in appropriately selected 
patients. Moreover, incorrect lead placement may be detrimental and 
lead to further dyssynchrony(30).
Using tissue Doppler strain imaging, a recent study has confi rmed 
that pacing at the site of maximal mechanical delay is associated with 
reverse remodeling,(26) a powerful predictor of a favourable clinical 
outcome(28,31). Echocardiography could be helpful at the time of 
implantation to optimise lead position. Ongoing clinical trials seek to 
address this issue.
POST-IMPLANTATION USE OF                                       
ECHOCARDIOGRAPHY FOR FOLLOW-UP AND
OPTIMISATION
The three primary aspects of programming or optimisation of 
resynchronisation therapy that have become salient to management 
have been the optimisation of atrio-ventricular (AV) delay, mechanical 
synchrony and interventricular timing. Although much attention has 
focused on the optimisation of the AV delay, it has become evident that 
optimisation of mechanical synchrony may be the most important 
parameter to target as an endpoint to ensure successful therapy.
Optimising Atrio-Ventricular Delay
Although AV-delay optimisation can clearly impact hemodynamics in 
patients undergoing CRT,(32,33) it has less infl uence on LV function than 
the optimal pacing site(34). An optimal AV delay is that which allows 
completion of the end-diastolic fi lling fl ow prior to ventricular 
contraction, thereby providing the longest diastolic fi lling time. The AV 
interval can be optimised using 2 methods: 
1.   calculating the AV-delay interval from pulsed Doppler measurement 
of the timing of mitral valve closure at a short and long AV-delay 
setting (mitral infl ow method)(35)
2.  determining the AV-delay that produces the greatest increase in the 
aortic velocity time integral (VTI) using continuous wave Doppler. 
A recent study has shown that the aortic VTI method may be 
superior to the mitral infl ow method in patients with a QRS interval 
>150ms. (36)
Optimisation of the Ventricular-to-Ventricular (VV)-Interval
In patients with heart failure and signifi cant conduction delay undergoing 
CRT, simultaneous stimulation of the LV and right ventricle (RV) may 
not be appropriate. Therefore, altering LV-RV stimulation by varying 
durations may further optimise LV resynchronisation. The benefi t of 
sequential versus simultaneous biventricular pacing (BVP) has been 
evaluated in a small study of 21 patients(37). This study used TDI with 
tissue tracking pre-operatively to identify regions displaying delayed 





FIGURE 8: Strain rate measures the speed of deformation (change in shape) of the 
myocardium. As with Strain Imaging, systolic motion of the segments towards the apex 
(towards the transducer) is ascribed a positive value and shortening of the segment a 
negative strain rate value. Simultaneous ECG recordings allow correct timing of events. 
This normal study depicts a negative systolic Strain Rate in the basal septum.
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individually tailored sequential rather than simultaneous BVP resulted in 
an additional increase in diastolic fi lling time, with a simultaneous 
signifi cant increase in LV ejection fraction from 30+5% to 34+6%. It has 
been recommended that the VV-interval be optimised before the AV-
interval, to prevent inappropriate AV-delay programming, which might 
reduce LV fi lling(33).
Assessment of Myocardial Remodeling
Myocardial remodeling is a complex process and not well understood. 
Positive remodeling is defi ned as a >15% reduction in LV end-systolic 
volume(28,31). This has been observed in about 54% - 64% of patients at 
3 months follow-up(38,39). Echocardiography has also demonstrated a 
reduction in the severity of mitral regurgitation in CRT responders. This 
is related, in part, to resynchronisation of papillary muscle contraction 
that restores mitral subvalvular size and function towards normal and 
improved atrioventricular coupling(31). The reduction in MR can be seen 
almost immediately after optimal CRT. 
EVALUATING CRT “NON-RESPONDERS”                         
If CRT has not achieved its anticipated response, the following questions 
should be addressed: 
1.  Has the physiology of CRT been optimised for this patient? 
Has diastolic timing been optimally adjusted? Has systolic 
resynchronisation been fully enhanced? All of these issues can be 
addressed using echocardiography.
2.  Is CRT being consistently delivered? Are the ventricles being 
consistently paced at all physiologic heart rates? Is the LV stimulus 
consistently suprathreshold? Is there consistent atrial and ventricular 
sensing? Answering these questions requires an understanding of 
how to use diagnostics from the CRT device. 
FUTURE DIRECTIONS                                                      
Some potential issues that may be addressed include: 
1. The role of echocardiography in the catheterisation laboratory to 
guide LV lead placement. It has been shown that, in patients with 
LBBB, RV apical pacing alters the activation wavefront of the LV 
compared with intrinsic rhythm(40). Perhaps echocardiography can 
be used in the catheterisation laboratory to ensure that RV pacing 
has not altered the LV segment with dyssynchrony. Also, the 
separate effects of RV, LV and BVP can be assessed.
2. The role of regional myocardial infarction on long-term clinical 
outcomes and whether echocardiography can address these 
issues.
3. The role of CRT in patients with heart failure and an EF<35% but 
with a QRS duration <120ms or a right bundle branch block 
pattern on ECG.
4. The role of CRT in those with dyssynchrony but with less severe 
symptoms of heart failure (NYHA functional class II) or with less 
severe LV dysfunction (EF 35% - 40%).
CONCLUSIONS                                                                 
Current guidelines recommend CRT in patients with reduced LV 
ejection fraction, a prolonged QRS interval and severe heart failure 
symptoms despite optimal medical therapy.  Based on these selection 
criteria, about one third of patients fail to respond. Echocardiography 
can be used to improve patient selection and should be included as 
part of the workup to identify potential candidates for CRT. In addition, 
echocardiography has an important role in the identifi cation of the 
optimal site for LV lead placement and in the optimisation of CRT 
programming with regard to the AV- and  VV- intervals. Echocardiography 
also allows assessment of resynchronisation and follow-up of patients 
after CRT.
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